International Patent: BLOOD BRAIN BARRIER SHUTTLES COMPRISING ANTIGEN-BINDING MOLECULES TARGETING INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR

GENEVA, Aug. 21 -- MULTIVERSE PHARMA INC. filed a patent application (US2026/015320) for “BLOOD BRAIN BARRIER SHUTTLES COMPRISING ANTIGEN-BINDING MOLECULES TARGETING INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR”. With publication no. WO/2026/174234, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....